ICAP Global Derivatives Limited

2 Broadgate

London

United Kingdom

EC2M 7UR

April 1, 2021

FOIA CONFIDENTIAL TREATMENT REQUEST

Sent via email to FOIAsubmissions@cftc.gov

Assistant Secretary of the CFTC for FOI,

 Privacy and Sunshine Acts Compliance

U.S. Commodity Futures Trading Commission

Three Lafayette Centre

1155 21st Street, N.W.

Washington, D.C. 20581

Re: Freedom of Information Act (“FOIA”) Confidential Treatment Request for 

Information Submitted to the CFTC by ICAP Global Derivatives Limited

Dear Assistant Secretary:

ICAP Global Derivatives Limited (“IGDL”), a swap execution facility registered with the 

Commodity Futures Trading Commission (“CFTC”), today submitted to the CFTC’s Division of 

Market Oversight a rule certification pursuant to CFTC Regulation 40.6 (the “IGDL Submission”

or “IGDL-2021-R-4”). The IGDL Submission was submitted via the CFTC Portal.

IGDL hereby requests, pursuant to CFTC Regulation 145.9, that Confidential Exhibit A, 

Confidential Exhibit B, and Confidential Exhibit C of the IGDL Submission (the “Confidential 

Documents”) be accorded confidential treatment on the grounds that disclosure would reveal 

confidential commercial and financial information and would be of material assistance to 

competitors of IGDL. Our specification of these grounds for confidential treatment shall not 

preclude us from identifying additional grounds for confidential treatment at a later time. Each 

page of the Confidential Documents has been labeled “Confidential Treatment Requested by ICAP 

Global Derivatives Limited” and numbered as provided on Schedule A attached hereto.

Additionally, IGDL requests FOIA confidential treatment of any notes, memoranda or other 

records created by or at the direction of the CFTC, its officers or staff members, that reflect, refer 

or relate to the Confidential Documents (the “Confidential Records”, and together with the 

Confidential Documents, the “Confidential Information”).
Assistant Secretary of the CFTC for FOI,

Privacy and Sunshine Acts Compliance

U.S. Commodity Futures Trading Commission

April 1, 2021

2

This request for FOIA confidential treatment is sought for as long as the CFTC remains in control 

and/or possession of any Confidential Information.

We request that if the CFTC receives a FOIA request for any Confidential Information, IGDL will 

be notified of such request in accordance with the CFTC’s regulations and have the opportunity to 

submit a written justification for confidential treatment of the Confidential Information.

In the event the CFTC or its staff provides any of the Confidential Information to another federal 

agency, we request that the CFTC provide a copy of this letter to such agency with the Confidential 

Information and further request that the CFTC or its staff inform such agency that IGDL has 

requested that this material be accorded confidential treatment. 

Please promptly inform Mr. Brian Donnelly, Chief Compliance Officer, IGDL at (201) 984-6956, 

or by email at bddonnelly@tullettprebon.com, of any request under FOIA seeking access to the 

Confidential Information to enable IGDL to further substantiate the grounds for confidential 

treatment. Thank you for your attention to this matter.

Very truly yours,

ICAP Global Derivatives Limited

By: __________________________

Name: Brian D. Donnelly

Title: Chief Compliance Officer

Date: April 1, 2021

Enclosure

cc: CFTC Division of Market Oversight (dmosubmissions@cftc.gov)

Nancy Markowitz, CFTC (nmarkowitz@cftc.gov)
Assistant Secretary of the CFTC for FOI,

Privacy and Sunshine Acts Compliance

U.S. Commodity Futures Trading Commission

April 1, 2021

3

SCHEDULE A

CONFIDENTIAL INFORMATION

Document Subject to Request for 

Confidential Treatment Pursuant to §145.9

Identifying Number and Code

IGDL-2021-R-4 – Confidential Exhibit A IGDL_0002249

IGDL-2021-R-4 – Confidential Exhibit B IGDL_0002250– IGDL_0002296

IGDL-2021-R-4 – Confidential Exhibit C IGDL_0002297– IGDL_0002343